Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
Global Stocks

Global Market Stocks Estimated To Be Trading At A Discount In October 2025

As global markets navigate through a period of cautious optimism, driven by mixed economic signals and hawkish commentary from central banks, investors are keenly assessing the landscape for opportunities. In this environment of fluctuating indices and tempered expectations for monetary policy easing, identifying stocks that may be undervalued becomes crucial for those looking to capitalize on potential market inefficiencies.

Name

Current Price

Fair Value (Est)

Discount (Est)

Tibet GaoZheng Explosive (SZSE:002827)

CN¥38.57

CN¥76.88

49.8%

Samyang Foods (KOSE:A003230)

₩1512000.00

₩3006664.22

49.7%

Midsummer (OM:MIDS)

SEK2.76

SEK5.45

49.3%

LINK Mobility Group Holding (OB:LINK)

NOK30.15

NOK59.61

49.4%

Kolmar Korea (KOSE:A161890)

₩77300.00

₩153922.72

49.8%

E-Globe (BIT:EGB)

€0.665

€1.31

49.4%

Devsisters (KOSDAQ:A194480)

₩48200.00

₩95431.37

49.5%

Dajin Heavy IndustryLtd (SZSE:002487)

CN¥47.21

CN¥93.18

49.3%

Cosmax (KOSE:A192820)

₩209000.00

₩413310.48

49.4%

Chanjet Information Technology (SEHK:1588)

HK$10.87

HK$21.51

49.5%

Click here to see the full list of 536 stocks from our Undervalued Global Stocks Based On Cash Flows screener.

Here’s a peek at a few of the choices from the screener.

Overview: Recordati Industria Chimica e Farmaceutica S.p.A. is a pharmaceutical company that researches, develops, produces, and sells its products across various international markets including Italy and the United States, with a market cap of €10.93 billion.

Operations: Recordati generates revenue from two main segments: Rare Diseases, contributing €950.29 million, and Specialty & Primary Care, which brings in €1.53 billion.

Estimated Discount To Fair Value: 17.7%

Recordati Industria Chimica e Farmaceutica is trading at €53, below its estimated fair value of €64.38, indicating potential undervaluation based on cash flows. The company’s earnings are forecast to grow 14.13% annually, outpacing the Italian market’s 9.3%. Despite a high debt level and a dividend not well covered by free cash flows, revenue growth is expected to surpass the Italian market rate at 7.1% per year.

BIT:REC Discounted Cash Flow as at Oct 2025

Overview: Stora Enso Oyj offers renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries both in Finland and internationally, with a market cap of €7.59 billion.

Credit: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button